Genomics Market Expanding with Technological Drive of Pharmaceutical Companies


Posted March 13, 2019 by RubyWills

Genomics is the sequencing and analysis of genome that uses DNA sequencing and bioinformatics for assembling and analyzing the genome functions.

 
Genomics Market: Demand Analysis and Growth Forecast

According to a recent business publication by IndustryARC titled “Genomics Market: By Product Types (Microarray chip, Sequencers, Others); By Services (Bioinformatics, Laboratory, Others); By Technique (PCR, Electrophoresis, others); By Application (Genotyping, SNP analysis, others); (By End-User (Anthropology, Diagnostics, Others); By Geography – Forecast (2019-2025),” there were opportunities worth $16.0 billion to 16.5 billion as of 2018, and the analyst estimates the demand to grow with a CAGR of 9.2% to 10.2% during the forecasted period of 2019 to 2025.

Genomics is the sequencing and analysis of the genome that uses DNA sequencing and bioinformatics for assembling and analyzing the genome functions. Genomics Market is undoubtedly influenced by global health imbalance, which is substantially divided into small and mid-size companies. Genomics is involved in determining complete DNA, DNA sequencing, and genesis mapping to understand diseases. According to the World Health Organization, Low- to middle-income countries account for 85% of the world’s population and 92% of the global burden of disease. Pharmaceutical companies are highly influenced by the genomics market for value chain. These companies can reduce cost by using genomics information that helps them in making better decisions. Considering achieving the global health goals by the government, the global health inequalities are to be brought down by providing an efficient and cost-effective initiative to the developing countries. The government is aiming at raising awareness of genomics amongst people that aren’t aware of it. This will eventually popularize the effectiveness of genomics and drive growth in the genomics market.

Browse 66 Market Tables, 177 Figures spread through 163 slides and an in-depth TOC “Genomics Market (2019 - 2025)”

Request for a free sample report: https://industryarc.com/pdfdownload.php?id=1275

Genomics Market: Leading Segment

North America is currently home for the genomics market. The market is gaining tremendous revenue due to the huge development in vaccines and drugs. Genomics is widely used in biotechnology, healthcare, agriculture, and diagnostics in North America due to which the North American region is flourishing with the regional genomics market share of nearly 39% to 40%. The drug discovery application of genomics is estimated to have a CAGR of 10.1% to 10.7% through to 2025. The country has plunge cost of series enabling the whole genome market series at a very less price.

Genomics Market: Market Trends

Since DNA sequences are very expensive the companies are mainly focusing on developing cost-effective sequencing methods and equipment. These products improve the data quality and are very useful for various applications such as whole genome protein binding replacing the old equipment. When the circulating tumor cells in DNA die, they release fragments in the bloodstream. Many R&D companies and sectors are exploring a lot of information for the biomarkers for cancers, as these cells grow quickly and cause damage to neighboring cells. This is chiefly influencing the genomics market growth.

New technologies have boosted the genomics market drastically. Biologists are launching revolutionary genomes in the market, by developing sequencing technologies which have led to high-quality plant and animal genomes. The biotechnology industry has grown in recent years and has generated good revenue. The genomic and biotech impacts the agriculture sector by improving the crop yielding quality and by developing crops that are stress tolerant. Biotechnology companies that are investing in Asian countries are PierianDx and ScienceVision.

Genomics Market: Competitive Landscape

Some of the key companies identified in the report that are currently holding majority genomics market shares are Cepheid, Inc., Affymetrix, Inc., Bio-Rad Laboratories, Inc., Agilent Technologies, GE Healthcare, Illumina, Inc.,, Danaher Corporation, and F. Hoffmann-La Roche.

Related Report:

Single-Cell Genome Sequencing Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth And Forecast 2019 - 2024

https://industryarc.com/Research/Single-Cell-Genome-Sequencing-Market-Research-503991

About IndustryARC:

IndustryARC is a research and consulting firm that publishes more than 500 reports annually in various industries, such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food & Beverages, Information Technology, Life sciences & Healthcare.

Contact Us:
Mr. Venkateshwar Reddy
Business Development Manager
Email: [email protected]
Contact Sales: 1-614-588-8538 (Ext-101)
Connect with us on LinkedIn - https://www.linkedin.com/company/industryarc
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By IndustryARC
Phone +1614-588-8538
Business Address Plot No. 56, HUDA Techno Enclave
Madhapur, Hyderabad, Telangana
Country India
Categories Advertising , Business , Health
Tags genomics , genomics market , genomics market share , genomics market size , genomics market value
Last Updated March 13, 2019